Krystian Fita

Krystian Fita

Auto-generated profile, based on publicly available information

Krystian Fita

Department of Neurosurgery, University Medical Center Hamburg-Eppendorf, Hamburg, Germany

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2020 in Clinical Cancer Research
Verified
Journal Article
Closed access
PDF file
MMMalte Mohme
Malte Mohme
CMCecile L. Maire
Cecile L. Maire
UGUlf Geumann
Ulf Geumann
SSSimon Schliffke
Simon Schliffke
LDLasse Dührsen
Lasse Dührsen
Nils Ole SchmidtNils Ole Schmidt
Nils Ole Schmidt
Purpose: Mesenchymal stem cells (MSCs) show an inherent brain tumor tropism that can be exploited for targeted delivery of therapeutic genes to invasive glioma. We assessed whether a motile MSC-based local immunomodulation is able to overcome the immunosuppressive glioblastoma microenvironment and to induce an antitumor immune response. Experimental design: We genetically modified MSCs to co-express high levels of IL-12 and IL-7 (MSCIL7/12, Apceth-301). Therapeutic efficacy was assessed in two immunocompetent orthotopic C57BL/6 glioma models using GL261 and CT2A. Immunomodulatory effects were assessed by multicolor flow-cytometry to profile immune activation and exhaustion of tumor-infiltrating immune cells. Diversity of the tumor-specific immune response as analyzed using T-cell receptor sequencing (TCRseq). Results: Intratumoral administration of MSCIL7/12 induced significant tumor growth inhibition and remission of established intracranial tumors, as demonstrated by MR imaging. Notably, up to 50% of treated mice survived long-term. Re-challenging of survivors confirmed long-lasting tumor immunity. Local treatment with MSCIL7/12 was well tolerated and led to a significant inversion of the CD4+/CD8+ T-cell ratio with an intricate, predominantly CD8+ effector T-cell mediated anti-tumor response. T-cell receptor sequencing demonstrated an increased diversity of TILs in MSCIL7/12-treated mice, indicating a broader tumor-specific immune response with subsequent oligoclonal specification during generation of long-term immunity. Conclusion: Local MSC-based immunomodulation is able to efficiently alter the immunosuppressive microenvironment in glioblastoma. The long-lasting therapeutic effects warrant a rapid clinical translation of this concept and have led to planning of a phase I/II study of apceth-301 in recurrent glioblastoma.

22 May 2015 in Structural Dynamics
Verified
Journal Article
Open access
PDF file
RSR. Schönherr
R. Schönherr
MKM. Klinge
M. Klinge
JRJ. M. Rudolph
J. M. Rudolph
KFK. Fita
K. Fita
DRD. Rehders
D. Rehders
LRLars Redecke
Lars Redecke
X-ray crystallography requires sufficiently large crystals to obtain structural insights at atomic resolution, routinely obtained in vitro by time-consuming screening. Recently, successful data collection was reported from protein microcrystals grown within living cells using highly brilliant free-electron laser and third-generation synchrotron radiation. Here, we analyzed in vivo crystal growth of firefly luciferase and Green Fluorescent Protein-tagged reovirus μNS by live-cell imaging, showing that dimensions of living cells did not limit crystal size. The crystallization process is highly dynamic and occurs in different cellular compartments. In vivo protein crystallization offers exciting new possibilities for proteins that do not form crystals in vitro.

1 October 2020 in Journal of Clinical Investigation
Verified
Journal Article
Closed access
PDF file
CMCecile Maire
Cecile Maire
MMMalte Mohme
Malte Mohme
MBMichael Bockmayr
Michael Bockmayr
KFKrystian D. Fita
Krystian D. Fita
KRKristoffer Riecken
Kristoffer Riecken
KLKatrin Lamszus
Katrin Lamszus
Immunotherapeutic strategies are increasingly important in neuro-oncology, and the elucidation of escape mechanisms that lead to treatment resistance is crucial. We investigated the impact of immune pressure on the clonal dynamics and immune escape signature by comparing glioma growth in immunocompetent versus immunodeficient mice. Glioma-bearing WT and Pd-1–/– mice survived significantly longer than immunodeficient Pfp–/– Rag2–/– mice. While tumors in Pfp–/– Rag2–/– mice were highly polyclonal, immunoedited tumors in WT and Pd-1–/– mice displayed reduced clonality with emergence of immune escape clones. Tumor cells in WT mice were distinguished by an IFN-γ–mediated response signature with upregulation of genes involved in immunosuppression. Tumor-infiltrating stromal cells, which include macrophages/microglia, contributed even more strongly to the immunosuppressive signature than the actual tumor cells. The identified murine immune escape signature was reflected in human patients and correlated with poor survival. In conclusion, immune pressure profoundly shapes the clonal composition and gene regulation in malignant gliomas.

17 March 2020 in Acta Neuropathologica
Verified
Journal Article
Open access
PDF file
FRFranz L. Ricklefs
Franz L. Ricklefs
KFKrystian D. Fita
Krystian D. Fita
RRRoman Rotermund
Roman Rotermund
APAndras Piffko
Andras Piffko
SSSimone Schmid
Simone Schmid
JFJörg Flitsch
Jörg Flitsch

5 May 2025 in Cancer Immunology Research
Verified
Journal Article
Closed access
SSSara C. Schulte
Sara C. Schulte
WPWolfgang Peter
Wolfgang Peter
GRGeorg Rosenberger
Georg Rosenberger
MSMoritz Schäfer
Moritz Schäfer
CMCecile Maire
Cecile Maire
MMMalte Mohme
Malte Mohme
Immune evasion is a hallmark of gliomas, yet the genetic mechanisms by which tumors escape immune surveillance remain incompletely understood. In this study, we systematically examined the presence of somatic mutations in HLA genes and genes encoding proteins involved in antigen presentation across isocitrate dehydrogenase wild-type and mutant gliomas using targeted next-generation sequencing. To address the challenges associated with detecting somatic mutations in these highly polymorphic and complex regions of the genome, we applied a combination of short-read and long-read sequencing techniques, extended the genetic region of interest (exons and introns), and applied a tailored bioinformatics analysis pipeline, which enabled an accurate evaluation of comprehensive sequencing data. Our analysis identified mutations in HLA class II and nonclassic HLA genes as well as genes associated with antigen presentation, such as TAP1/2 and B2M. Three-dimensional modeling of individual mutations simulated the potential impact of somatic mutations in TAP1 and B2M on the encoded protein configuration. The presence of somatic mutations supports the role of antigen-presenting genes in the pathophysiology and potential immune escape of gliomas. Our data demonstrated an increased frequency of such mutations in recurrent glioblastoma, potentially resulting from a positive selection or mutagenic enrichment of tumor cells during tumor progression. Taken together, this research generates new insights and hypotheses for the functional analysis and optimization of immunotherapy strategies for gliomas, which may guide personalized treatment paradigms.

2 July 2025
Verified
Other
Open access
SSSara C. Schulte
Sara C. Schulte
WPWolfgang Peter
Wolfgang Peter
GRGeorg Rosenberger
Georg Rosenberger
MSMoritz Schäfer
Moritz Schäfer
CMCecile Maire
Cecile Maire
MMMalte Mohme
Malte Mohme
Immune evasion is a hallmark of gliomas, yet the genetic mechanisms by which tumors escape immune surveillance remain incompletely understood. In this study, we systematically examined the presence of somatic mutations in HLA genes and genes encoding proteins involved in antigen presentation across isocitrate dehydrogenase wild-type and mutant gliomas using targeted next-generation sequencing. To address the challenges associated with detecting somatic mutations in these highly polymorphic and complex regions of the genome, we applied a combination of short-read and long-read sequencing techniques, extended the genetic region of interest (exons and introns), and applied a tailored bioinformatics analysis pipeline, which enabled an accurate evaluation of comprehensive sequencing data. Our analysis identified mutations in HLA class II and nonclassic HLA genes as well as genes associated with antigen presentation, such as TAP1/2 and B2M. Three-dimensional modeling of individual mutations simulated the potential impact of somatic mutations in TAP1 and B2M on the encoded protein configuration. The presence of somatic mutations supports the role of antigen-presenting genes in the pathophysiology and potential immune escape of gliomas. Our data demonstrated an increased frequency of such mutations in recurrent glioblastoma, potentially resulting from a positive selection or mutagenic enrichment of tumor cells during tumor progression. Taken together, this research generates new insights and hypotheses for the functional analysis and optimization of immunotherapy strategies for gliomas, which may guide personalized treatment paradigms.